- "Prof.
Christopher Huber".
Biontech Biography.
Biontech.
Retrieved 5
August 2021. "SEC
Filing |
BioNTech". investors.
biontech.de. p. 130.
Retrieved 28 December...
- The Pfizer–
BioNTech COVID-19 vaccine, sold
under the
brand name Comirnaty, is an mRNA-based COVID-19
vaccine developed by the
German biotechnology company...
- at Bio
NTech's laboratories in Mainz, Germany, just days
after the SARS-Cov-2
genetic sequence was
first made public. In
September 2020,
BioNTech received...
- Pfizer–
BioNTech's BNT162b2 COVID-19
vaccine for
widespread use. On 11 December, the FDA gave
emergency use
authorization for the Pfizer–
BioNTech COVID-19...
- ****ociated with
BioNTech RNA Pharmaceuticals,
first as a vice
president and
promoted to
senior vice
president in 2019. In 2022, she left
BioNTech to devote...
-
regulatory authority recognized by the
World Health Organization (WHO): Pfizer–
BioNTech, Oxford–AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin...
-
delivery schedule for Pfizer-
BioNTech’s COVID-19 vaccine." By the end of September,
Canada will
receive the 40
million Pfizer-
BioNTech doses.
Major General Fortin...
-
begin m****
vaccination with the Pfizer–
BioNTech COVID-19 vaccine. In addition,
Singapore approves the Pfizer–
BioNTech COVID-19 vaccine, with
other companies...
- On 25
January 2021, the TGA
provisionally approved the two-dose Pfizer–
BioNTech COVID-19 vaccine,
named COMIRNATY, for use
within Australia. The provisional...
-
approved the Pfizer-
BioNTech vaccine for
section 21
Emergency Use Authorisation. A
trial ending in
March 2021 of the Pfizer-
BioNTech's COVID-19
vaccine appeared...
